Dermatitis herpetiformis.
D000936:Antigen-Antibody Complex; D001323:Autoantibodies / Q000032:analysis; D002446:Celiac Disease / Q000150:complications / Q000276:immunology; D003165:Complement System Proteins / Q000032:analysis; D003429:Cross Reactions; D003622:Dapsone / Q000627:therapeutic use; D003874:Dermatitis Herpetiformis / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D004035:Diet Therapy; D005455:Fluorescent Antibody Technique; D005983:Glutens; D006649:Histocompatibility Antigens; D006801:Humans; D007111:Immunity, Cellular; D007070:Immunoglobulin A / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007413:Intestinal Mucosa / Q000473:pathology; D007421:Intestine, Small / Q000473:pathology; D012155:Reticulin; D012867:Skin / Q000276:immunology / Q000473:pathology
D000936:Antigen-Antibody Complex; D001323:Autoantibodies; D006649:Histocompatibility Antigens; D007070:Immunoglobulin A; D007075:Immunoglobulin M; D012155:Reticulin; D005983:Glutens; D003622:Dapsone; D003165:Complement System Proteins